Trilostane
(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile
Molecular Identity
Trilostane
(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile
PubChem CID: 656583
Trilostane can cause developmental toxicity according to state or federal government labeling requirements.
2D Structure
Properties
C20H27NO3
Molecular Formula
329.40
Molecular Weight
g/mol
329.1991
Exact Mass
Da
2.9
XLogP
Drug-like (Lipinski: < 5)
76.8
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
4
H-Bond Acceptors
692
Complexity
SMILES
Canonical SMILES
SMILES: CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)CIsomeric SMILES
SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(CC(=C([C@H]4O5)O)C#N)CSynonyms(20)
Trilostane13647-35-3ModrenalDesopanVetorylModrastaneTrilostanoWin-24540TrilostanumDTXSID9023706WIN 24,540L0FPV48Q5RWin 24540CHEBI:32260NSC-758904
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Trilostane
Loading drug network...